YPT-17649-21891
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 674 / KS
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
- 2021-01-21
- 2021-01-26
-
2021-01-28
Dose 2 — Pfizer-BioNTech
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-30
- 2021-02-01
- 2021-02-02
- 2021-02-04
- 2021-02-11
- 2021-02-21
- 2021-02-25
- 2021-03-06
- 2021-03-11
- 2021-04-29
- 2021-07-31
-
2022-01-28
Survey response — 12 months, dose 2MedDRA: Paranasal sinus hypersecretion, Sinus headache — Feeling: PoorFree text: Sinus drainage/headacheMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech |
Free text
Release 11 — 12 months, dose 2
Symptoms: Sinus drainage/headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Sinus headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release